These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39061823)

  • 1. Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Mateos D; Casares M; Gómez C; Ugarriza L; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Jun; 13(7):. PubMed ID: 39061823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Argelich E; Casares M; Ugarriza L; Llompart I; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Adherence to the Mediterranean Diet after Lifestyle Intervention Improves Oxidative and Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Gámez JM; Tejada S; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Impact of Nutritional Intervention with Increased Polyphenol Intake and Physical Activity Promotion on Oxidative and Inflammatory Profiles in Patients with Metabolic Syndrome.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Mateos D; Ugarriza L; Gómez C; Sureda A; Tur JA
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Llompart I; Abete I; Zulet MÁ; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediterranean Diet Improves Plasma Biomarkers Related to Oxidative Stress and Inflammatory Process in Patients with Non-Alcoholic Fatty Liver Disease.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; Llompart I; Mateos D; Casares M; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction-associated fatty liver disease: Results from two prospective cohorts.
    Zhang Y; Zhang T; Liu Y; Bai S; Jiang J; Zhou H; Luan J; Cao L; Lv Y; Zhang Q; Liu L; Sun S; Wang X; Zhou M; Jia Q; Song K; Zhang H; Chang Q; Fan X; Ding Y; Chen L; Zhao Y; Niu K; Xia Y
    Diabetes Metab Syndr; 2023 Oct; 17(10):102873. PubMed ID: 37804689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease.
    Su W; Chen M; Xiao L; Du S; Xue L; Feng R; Ye W
    Front Public Health; 2022; 10():1047794. PubMed ID: 36420005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis.
    Ponte B; Pruijm M; Marques-Vidal P; Martin PY; Burnier M; Paccaud F; Waeber G; Vollenweider P; Bochud M
    Nephrol Dial Transplant; 2013 Sep; 28(9):2329-39. PubMed ID: 23825103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: The MEDINA randomized controlled trial.
    Reddy A; Gatta PD; Mason S; Nicoll AJ; Ryan M; Itsiopoulos C; Abbott G; Johnson NA; Sood S; Roberts SK; George ES; Tierney AC
    Nutr Res; 2023 Nov; 119():98-108. PubMed ID: 37801761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study.
    Otoda T; Sekine A; Uemoto R; Tsuji S; Hara T; Tamaki M; Yuasa T; Tamaki T; Matsuhisa M; Aihara KI
    Diabetes Ther; 2024 Jan; 15(1):127-143. PubMed ID: 37883001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Energy-Reduced Mediterranean Diet, Physical Activity, and Body Composition: An Interim Subgroup Analysis of the PREDIMED-Plus Randomized Clinical Trial.
    Konieczna J; Ruiz-Canela M; Galmes-Panades AM; Abete I; Babio N; Fiol M; Martín-Sánchez V; Estruch R; Vidal J; Buil-Cosiales P; García-Gavilán JF; Moñino M; Marcos-Delgado A; Casas R; Olbeyra R; Fitó M; Hu FB; Martínez-Gonzalez MÁ; Martínez JA; Romaguera D; Salas-Salvadó J
    JAMA Netw Open; 2023 Oct; 6(10):e2337994. PubMed ID: 37851444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.
    George ES; Reddy A; Nicoll AJ; Ryan MC; Itsiopoulos C; Abbott G; Johnson NA; Sood S; Roberts SK; Tierney AC
    Liver Int; 2022 Jun; 42(6):1308-1322. PubMed ID: 35357066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mediterranean diet adoption improves metabolic, oxidative, and inflammatory abnormalities in Algerian metabolic syndrome patients.
    Bekkouche L; Bouchenak M; Malaisse WJ; Yahia DA
    Horm Metab Res; 2014 Apr; 46(4):274-82. PubMed ID: 24446153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD.
    Navaneethan SD; Kirwan JP; Remer EM; Schneider E; Addeman B; Arrigain S; Horwitz E; Fink JC; Lash JP; McKenzie CA; Rahman M; Rao PS; Schold JD; Shafi T; Taliercio JJ; Townsend RR; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):44-55. PubMed ID: 32798563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.